Compare JBI & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JBI | ACHC |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Building Products | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 987.0M | 1.1B |
| IPO Year | N/A | N/A |
| Metric | JBI | ACHC |
|---|---|---|
| Price | $7.07 | $16.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $10.17 | ★ $20.07 |
| AVG Volume (30 Days) | 1.0M | ★ 4.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.44 |
| Revenue Next Year | $1.58 | $3.49 |
| P/E Ratio | $21.01 | ★ $13.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.73 | $11.43 |
| 52 Week High | $10.80 | $42.85 |
| Indicator | JBI | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 66.81 |
| Support Level | $6.57 | $13.30 |
| Resistance Level | $7.48 | $17.11 |
| Average True Range (ATR) | 0.27 | 0.83 |
| MACD | 0.01 | 0.41 |
| Stochastic Oscillator | 54.10 | 85.48 |
Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.